Skip to content
Study details
Enrolling now

EMPOWER Trial - Carillon Mitral Contour System® for Heart Failure

Cardiac Dimensions, Inc.
NCT IDNCT03142152ClinicalTrials.gov data as of Apr 2026
Target enrollment

300

Study length

about 13 years

Ages

18+

Locations

75 sites in AZ, CA, CO +23

What this study is about

This trial is testing a new device, the Carillon Mitral Contour System®, to help people with heart failure and functional mitral regurgitation. The goal is to see if this device improves their condition.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Guideline Directed Heart Failure Medication
  • 2.Use Carillon Mitral Contour System

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Primary Safety Objective - Freedom from Major Adverse Events

Secondary: Exploratory Secondary Endpoint 1 - Change in Six-Minute Walk Distance, Exploratory Secondary Endpoint 2 - Change in KCCQ

Body systems

Cardiology / Heart